The Valley Desk

Clinical trial reportHeadachePublished

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Headache
Published
Subject terms
Humans; Chronic Disease; Neuromuscular Agents; Double-Blind Method; Quality of Life; Adult; Middle Aged; Female; Male; Migraine Disorders; Botulinum Toxins, Type A; Outcome Assessment, Health Care
PubMed ID
38982666
Added to directory
Source checked

Report a correction or request removal